Utilizing personalized tumor-specific methylation haplotypes of circulating tumor DNA for monitoring minimal residual disease in hepatocellular carcinoma patients after curative resection

被引：1
|
作者：
Yang, X. [1 ]
Guo, D. [1 ]
Zhang, S-Y. [1 ]
Xu, M-J. [2 ]
Chen, H. [2 ]
Ma, C. [2 ]
Su, M-Y. [2 ]
He, Q. [2 ]
Zhang, Y. [2 ]
Su, Z. [2 ]
Liu, R. [2 ]
Fan, J. [1 ]
Zhou, J. [1 ]
机构：
[1] Fudan Univ, Zhongshan Hosp Affiliated, Dept Liver Surg & Transplantat, Shanghai, Peoples R China
[2] Singlera Genom Inc, R&D, Shanghai, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.08.1018
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
958P
引用
收藏
页码：S661 / S662
页数：2
相关论文
共 50 条
  • [1] Utilization of personalized tumor-specific methylation haplotypes of circulating DNA to monitor minimal residual disease in patients with hepatocellular carcinoma undergoing curative resection
    Yang, Xin-Rong
    Guo, De-Zhen
    Zhang, Shi-Yu
    Xu, Min-Jie
    Chen, Hua
    Ma, Cheng-Cheng
    Fu, Rui-Qing
    Su, Ming-Yang
    He, Qi-Ye
    Zhang, Yun-Zhi
    Su, Zhi-Xi
    Liu, Rui
    Fan, Jia
    Zhou, Jian
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [2] Plasma-only circulating tumor DNA analysis detects minimal residual disease and predicts early relapse in hepatocellular carcinoma patients undergoing curative resection
    Xu, Yuyan
    Cai, Jianpeng
    Zhong, Kaihang
    Wen, Yaohong
    Cai, Lei
    He, Guolin
    Liao, Hangyu
    Zhang, Cheng
    Fu, Shunjun
    Chen, Tingting
    Cai, Jinping
    Zhong, Xuefeng
    Chen, Chunzhu
    Huang, Mengli
    Cheng, Yuan
    Pan, Mingxin
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [3] Personalized tumor-specific DNA junctions to detect circulating tumor in patients with endometrial cancer
    Grassi, Tommaso
    Harris, Faye R.
    Smadbeck, James B.
    Murphy, Stephen J.
    Block, Matthew S.
    Multinu, Francesco
    Klein, Janet L. Schaefer
    Zhang, Piyan
    Karagouga, Giannoula
    Liu, Minetta C.
    Larish, Alyssa
    Lemens, Maureen A.
    Sommerfield, Marla Kay S.
    Cappuccio, Serena
    Cheville, John C.
    Vasmatzis, George
    Mariani, Andrea
    PLOS ONE, 2021, 16 (06):
  • [4] Personalized circulating tumor DNA in patients with hepatocellular carcinoma: a pilot study
    Pommergaard, H. C.
    Yde, C. W.
    Ahlborn, L. B.
    Andersen, C. L.
    Henriksen, T., V
    Hasselby, J. P.
    Rostved, A. A.
    Sorensen, C. L.
    Rohrberg, K. S.
    Nielsen, F. C.
    Rasmussen, A.
    MOLECULAR BIOLOGY REPORTS, 2022, 49 (02) : 1609 - 1616
  • [5] Personalized circulating tumor DNA in patients with hepatocellular carcinoma: a pilot study
    H. C. Pommergaard
    C. W. Yde
    L. B. Ahlborn
    C. L. Andersen
    T. V. Henriksen
    J. P. Hasselby
    A. A. Rostved
    C. L. Sørensen
    K. S. Rohrberg
    F. C. Nielsen
    A. Rasmussen
    Molecular Biology Reports, 2022, 49 : 1609 - 1616
  • [6] Circulating Tumor DNA as a Marker of Minimal Residual Disease After Radical Resection of Colorectal Liver Metastases
    Marmorino, Federica
    Prisciandaro, Michele
    Giordano, Mirella
    Ortolan, Elisa
    Crucitta, Stefania
    Manca, Paolo
    Antoniotti, Carlotta
    Valenti, Marta Maria
    Danesi, Romano
    Conca, Veronica
    Mazzoli, Giacomo
    Boccaccino, Alessandra
    Carullo, Martina
    Martinetti, Antonia
    Sottotetti, Elisa
    Masi, Gianluca
    Sposito, Carlo
    Zaffaroni, Nadia
    Milione, Massimo
    Fontanini, Gabriella
    Del Re, Marzia
    Pietrantonio, Filippo
    Cremolini, Chiara
    JCO PRECISION ONCOLOGY, 2022, 6
  • [7] Detection of tumor-specific marker for minimal residual disease in multiple myeloma patients
    Sedlarikova, Lenka
    Kubiczkova, Lena
    Kryukov, Fedor
    Pelcova, Jana
    Adam, Zdenek
    Pour, Ludek
    Hajek, Roman
    Sevcikova, Sabina
    BIOMEDICAL PAPERS-OLOMOUC, 2015, 159 (04): : 554 - 561
  • [8] Personalized circulating tumour DNA assay for the detection of minimal residual disease in CRC patients after resection of metastases
    Loupakis, F.
    Derouazi, M.
    Murgioni, S.
    Rizzato, M. D.
    Sharma, S.
    Renner, D.
    Shchegrova, S.
    Sethi, H.
    Zimmermann, B.
    Aleshin, A.
    Schirripa, M.
    Munari, G.
    Dei Tos, A. P.
    Lonardi, S.
    Fassan, M.
    ANNALS OF ONCOLOGY, 2020, 31 : S413 - S413
  • [9] Personalized, tumor-informed, circulating tumor DNA assay for detecting minimal residual disease in non-small cell lung cancer patients receiving curative treatments
    Oh, Youjin
    Yoon, Sung Mi
    Lee, Jeeyeon
    Park, Joo Hee
    Lee, Soowon
    Hong, Timothy
    Chung, Liam Il-young
    Sudhaman, Sumedha
    Riddell, Timothy
    Palsuledesai, Charuta C.
    Krainock, Michael
    Liu, Minetta C.
    Chae, Young Kwang
    THORACIC CANCER, 2024, 15 (13) : 1095 - 1102
  • [10] Personalized neoantigen DNA vaccines expand tumor-specific T cells in the periphery which infiltrate the tumor in hepatocellular carcinoma
    Perales, Renzo
    Yarchoan, Mark
    Cooch, Neil
    Sardesai, Niranjan
    Perales-Puchalt, Alfredo
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345